TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
|
|
||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
PURETECH HEALTH PLC |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
Yes |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
No |
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
No |
|||
An event changing the breakdown of voting rights |
No |
|||
Other (please specify): |
No |
|||
3. Full name of person(s) subject to the notification obligation: iii |
Recordati SA Chemical and Pharmaceutical Company |
|||
4. Full name of shareholder(s) (if different from 3.):iv |
|
|||
5. Date of the transaction and date on which the threshold is crossed or reached: v |
12 June 2017 |
|||
6. Date on which issuer notified: |
13 June 2017 |
|||
7. Threshold(s) that is/are crossed or reached: vi, vii |
Below 3% |
|||
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||||
Class/type of shares
if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
||||||||||||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x |
||||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||||
GB00BY2Z0H74 |
9,554,140 |
9,554,140 |
0 |
0 |
0 |
0% |
0 |
|||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
|
|
|
|
|
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial instrument |
Exercise price |
Expiration date xvii |
Exercise/ Conversion period xviii |
Number of voting rights instrument refers to |
% of voting rights xix, xx |
|||||||||||
|
|
|
|
|
Nominal |
Delta |
||||||||||
|
|
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
0 |
0% |
|||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
||
|
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
|
|
11. Number of voting rights proxy holder will cease to hold: |
|
|
12. Date on which proxy holder will cease to hold voting rights: |
|
|
|
||
13. Additional information: |
This transfer of voting rights relates to a merger by absorption of Recordati SA Chemical and Pharmaceutical Company into Recordati S.p.A, with Recordati S.p.A as the surviving entity. |
|
14. Contact name: |
Silvia Signoretti |
|
15. Contact telephone number: |
+39 02 48787533 |
|